Incorporation of a lauric acid-conjugated GRGDS peptide directly into the matrix of a poly(carbonate-urea)urethane polymer for use in cardiovascular bypass graft applications
✍ Scribed by Asmeret G. Kidane; Geoffrey Punshon; Henryk J. Salacinski; Bala Ramesh; Audrey Dooley; Michael Olbrich; Johannes Heitz; George Hamilton; Alexander M. Seifalian
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 668 KB
- Volume
- 79A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Gly–Arg–Gly–Asp–Ser (GRGDS) was modified by conjugation to lauric acid (LA) to facilitate incorporation into the matrix of a poly(carbonate‐urea)urethane (PCU) used in vascular bypass grafts. GRGDS and LA‐GRGDS were synthesized using solid phase Fmoc chemistry and characterized by high performance liquid chromatography and Fourier transform infrared spectroscopy. LA‐GRGDS was passively coated and incorporated as nanoparticle dispersion on the PCU films. Biocompatibility of the modified surfaces was investigated. Endothelial cells seeded on LA‐GRGDS coated and incorporated PCU showed after 48 h and 72 h a significant (p < 0.05) increase in metabolism compared with unmodified PCU. The platelet adhesion and hemolysis studies showed that the modification of PCU had no adverse effect. In conclusion, LA‐conjugated RGD derivatives, such as LA‐GRGDS, that permit solubility into solvents used in solvent casting methodologies should have wide applicability in polymer development for use in coronary, vascular, and dialysis bypass grafts, and furthermore scaffolds utilized for tissue regeneration and tissue engineering. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006